GEN Exclusives

More »
Stem Cells - Related Content

THIS KEYWORD IS SPONSORED BY:

  • Insight & Intelligence™
  • More »

STEMCELL Technologies

Hematopoietic Colony Imaging System

STEMvision™ is a bench-top instrument and computer system designed specifically for automated imaging and counting of hematopoietic colonies in the colony-forming unit assay. This system is meant to be used with MethoCult™ media and meniscus-free S

Cellectis bioresearch

iPS Cell Lines

The iPS Engineering Hub™ service can provide users with customized iPS cell lines engineered with TALEN™ technology. Donated somatic cells are reprogrammed by means of co-expressing four factors (Oct-4, SOX2, c-Myc, and Klf-4) by nonintegrating tec

Life Technologies

Stem Cell Medium

Essential 6™ medium is designed for reprogramming, expanding, and differentiating pluripotent stem cells. Along with Essential 8™ media, it can streamline the generation, expansion, and differentiation of pluripotent stem cells by offering a feeder

Life Technologies

qRT-PCR Assay

Offered in partnership with Harvard University, the TaqMan® hPSC Scorecard™ panel and accompanying software is a qRT-PCR assay that integrates gene expression analysis with bioinformatics for a scorecard for the cells in question. The hPSC Sco

EMD Millipore

Mesenchymal Stem Cell Medium

OsteoMAX-XF™ is a fully defined xeno-free medium for the differentiation of mesenchymal stem cells into osteocytes. The media allows mineralization to be detected in less than a week and produces consistent and potent osteogenic differentiation. Th

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?